SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001102948-19-000001
Filing Date
2019-05-29
Accepted
2019-05-29 17:17:15
Documents
1
Period of Report
2019-05-24

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3842
  Complete submission text file 0001102948-19-000001.txt   5442
Mailing Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205
Business Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205 9739260816
INTEGRATED BIOPHARMA INC (Issuer) CIK: 0001016504 (see all company filings)

IRS No.: 222407475 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CDS INTERNATIONAL HOLDINGS 3299 NW SECOND AVE BOCA RATON FL 33431
Business Address
DESANTIS CARL (Reporting) CIK: 0001102948 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31668 | Film No.: 19863197